BOIRON SA (BOI.PA) Stock Fundamental Analysis
EPA:BOI - Euronext Paris - Matif - FR0000061129 - Common Stock - Currency: EUR
Taking everything into account, BOI scores 4 out of 10 in our fundamental rating. BOI was compared to 50 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for BOI as it has an excellent financial health rating, but there are worries on the profitability. BOI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BOI had positive earnings in the past year.
BOI had a positive operating cash flow in the past year.
In the past 5 years BOI has always been profitable.
BOI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.97%, BOI is doing worse than 62.00% of the companies in the same industry.
BOI's Return On Equity of 3.00% is on the low side compared to the rest of the industry. BOI is outperformed by 62.00% of its industry peers.
BOI has a worse Return On Invested Capital (2.54%) than 62.00% of its industry peers.
BOI had an Average Return On Invested Capital over the past 3 years of 5.61%. This is significantly below the industry average of 14.75%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROIC | 2.54% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
1.3 Margins
With a Profit Margin value of 2.33%, BOI perfoms like the industry average, outperforming 42.00% of the companies in the same industry.
In the last couple of years the Profit Margin of BOI has declined.
BOI has a Operating Margin of 3.23%. This is in the lower half of the industry: BOI underperforms 60.00% of its industry peers.
BOI's Operating Margin has declined in the last couple of years.
BOI has a Gross Margin (73.58%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BOI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% |
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
BOI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BOI has about the same amount of shares outstanding.
BOI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BOI has a worse debt to assets ratio.
2.2 Solvency
BOI has an Altman-Z score of 3.22. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
BOI's Altman-Z score of 3.22 is in line compared to the rest of the industry. BOI outperforms 52.00% of its industry peers.
BOI has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.63, BOI belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that BOI is not too dependend on debt financing.
The Debt to Equity ratio of BOI (0.03) is better than 86.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 3.22 |
ROIC/WACC0.33
WACC7.82%
2.3 Liquidity
A Current Ratio of 2.51 indicates that BOI has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.51, BOI is doing good in the industry, outperforming 80.00% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that BOI should not have too much problems paying its short term obligations.
BOI's Quick ratio of 1.61 is amongst the best of the industry. BOI outperforms 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.36%.
Measured over the past years, BOI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.40% on average per year.
The Revenue has decreased by -1.15% in the past year.
BOI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.63% yearly.
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
3.2 Future
The Earnings Per Share is expected to grow by 2.73% on average over the next years.
Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 34.00, BOI can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BOI is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
BOI is valuated rather expensively when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.56, the valuation of BOI can be described as reasonable.
Based on the Price/Forward Earnings ratio, BOI is valued a bit cheaper than 74.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BOI to the average of the S&P500 Index (21.70), we can say BOI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34 | ||
| Fwd PE | 9.56 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOI indicates a rather cheap valuation: BOI is cheaper than 90.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BOI is valued a bit cheaper than 66.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.43 | ||
| EV/EBITDA | 5.66 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BOI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.15
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BOI has a Yearly Dividend Yield of 5.39%, which is a nice return.
Compared to an average industry Dividend Yield of 3.03, BOI pays a better dividend. On top of this BOI pays more dividend than 94.00% of the companies listed in the same industry.
BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.39% |
5.2 History
The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
BOI pays out 206.77% of its income as dividend. This is not a sustainable payout ratio.
DP206.77%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPA:BOI (7/1/2025, 7:00:00 PM)
22.1
-0.3 (-1.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap387.86M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.39% |
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP206.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34 | ||
| Fwd PE | 9.56 | ||
| P/S | 0.8 | ||
| P/FCF | 16.43 | ||
| P/OCF | 9.81 | ||
| P/B | 1.03 | ||
| P/tB | 1.5 | ||
| EV/EBITDA | 5.66 |
EPS(TTM)0.65
EY2.94%
EPS(NY)2.31
Fwd EY10.47%
FCF(TTM)1.34
FCFY6.09%
OCF(TTM)2.25
OCFY10.19%
SpS27.78
BVpS21.55
TBVpS14.77
PEG (NY)6.15
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROCE | 3.39% | ||
| ROIC | 2.54% | ||
| ROICexc | 3.01% | ||
| ROICexgc | 4.32% | ||
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% | ||
| FCFM | 4.84% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexcg growth 3Y-33.41%
ROICexcg growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.18 | ||
| Cap/Depr | 37.59% | ||
| Cap/Sales | 3.27% | ||
| Interest Coverage | 14.49 | ||
| Cash Conversion | 68.03% | ||
| Profit Quality | 208.21% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 3.22 |
F-Score7
WACC7.82%
ROIC/WACC0.33
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-62.79%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.06%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y-13.1%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%